Articles published by Immix Biopharma, Inc.![]()
Immix Biopharma to Present at the 2023 JMP Securities Hematology and Oncology Summit
November 30, 2023
Via GlobeNewswire
Tickers
IMMX
![]() ![]()
Immix Biopharma Announces FDA Approval of IND Application for CAR-T NXC-201, Enabling U.S. Patient Dosing
November 21, 2023
Via GlobeNewswire
Tickers
IMMX
![]() ![]() ![]() ![]()
Immix Biopharma Completes 3rd NXC-201 Engineering Batch at its U.S. CAR-T Manufacturing Site
October 16, 2023
Via GlobeNewswire
Tickers
IMMX
![]() ![]() ![]() ![]()
Immix Biopharma Subsidiary Nexcella Completes 2nd NXC-201 Engineering Batch at its U.S. CAR-T Manufacturing Site
September 19, 2023
Via GlobeNewswire
Tickers
IMMX
![]() ![]() Via GlobeNewswire
Tickers
IMMX
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() Via GlobeNewswire
Tickers
IMMX
![]() ![]() ![]() ![]() Via GlobeNewswire
Tickers
IMMX
![]() Via GlobeNewswire
Tickers
IMMX
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|